TABLE 2.
Patient | Blocking function | Contactin epitope | Reactivity against |
||||
---|---|---|---|---|---|---|---|
Caspr | Tunicamycin-treated | Complex N-glycans | Mannose-rich | N457Q/N473Q/N494Q | |||
1 | + | Ig | − | − | + | + | + |
2 | + | Ig | − | − | + | + | − |
3 | + | Full-length | + | − | − | + | + |
4 | + | Ig | − | − | + | + | + |